SternMaid has invested €14m in its Wittenburg factory to enlarge capacity and extend the range of its products and services, involving the introduction of new fluid bed technology.
Manufacturers trying to prove the similarity of their biosimilars must consider that regulations and reference medicines differ in different markets says Pfizer.
Stricter GMP requirements in Peru are increasing the time it takes to get drugs approved and may not be giving regulators any useful additional information.
in-PharmaTechnologist.com presents its weekly round up of the latest movers and shakers in the world of pharmaceuticals, including news from Cytos, Ablynx and Baxter.
Piramal Healthcare wants to add sterile injectables to its offering but is unwilling to overpay for facilities owned by 'value focused' private equity groups.
in-PharmaTechnologist.com presents its weekly round-up of the new faces and changing places in the pharma biz, including news this week from BIA, Tolera and Alexar.
Scotland’s emergence as a biopharma hub – as evidenced by announcements by SAFC and Quintiles last week – is due to Government support, electronic health records and speedy trial approvals says Scottish Enterprise.
A transdermal patch technology developed by 3M Drug Delivery could lead to new injection free, compliance-boosting treatments for postmenopausal osteoporosis.
Outsourcing-Pharma.com presents its weekly round-up of the latest appointments in the pharma services industry, including news from Chiltern, Novacep and Emergent.
Drugmakers in Pakistan are suffering and parliament needs to implement on the proposed Drug Regulatory Authority (DRA) according to the Pakistan Pharmaceutical Manufacturers Association (PPMA).
The Mann who bought Marken for investment group Apax Partners has stepped down, describing the deal for the logistics contractor as one of the ‘tough ones’.
